Pathogenic Germline Variants ID'd in Patients With Lung Cancer
About 15 percent of patients diagnosed with lung cancer had PGVs, most of which were potentially clinically actionable
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.